OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Alzheimers Disease is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer’s Disease Not Using Neuroimaging Biomarkers: A Systematic Review	151
Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy	140
Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study	139
Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward	101
Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study	98
Postmortem tau in the CA2 region of the hippocampus in older adult men who participated in youth amateur American-style football	87
In-silico Codon Context and Synonymous Usage Analysis of Genes for Molecular Mechanisms Inducing Autophagy and Apoptosis with Reference to Neurodegenerative Disorders	80
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer’s Disease Treatment	75
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	74
A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks	71
Associations Between Midlife Menopausal Hormone Therapy Use, Incident Diabetes, and Late Life Memory in the Wisconsin Longitudinal Study	71
Association Between Carotid Plaque and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study	60
A Systematic Review of Prospective Memory Interventions Across Stages of Dementia-Related Disorders	56
Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints	56
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series	56
Joint Computational/Cell-Based Approach for Screening Inhibitors of Tau Oligomerization: A Proof-of-Concept Study	55
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer’s Disease	54
White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults	53
GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer’s Disease	51
Understanding of Dementia in the Polish Language: A Frame Semantic Approach	49
A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan	49
Cognitive Impairment and Associated Factors Among Adults with Type 2 Diabetes Mellitus in Bahir Dar City Referral Hospitals, 2021: Cross-Sectional Study	48
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	47
p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice	47
The association between dual sensory impairment and dementia: A systematic review and meta-analysis	47

Education attainment and nutritional status in the prevention of cognitive impairment in the hospitalized Chinese elderly	46
Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects	46
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia	45
Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study	44
Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging	44
Alzheimer’s Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia	44
Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months	43
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol	42
Relationship Between Endothelial Function, Vital Parameters, and Cognitive Performance in Community Dwellers with Subjective Cognitive Decline: An Observational Study with Six Months Follow Up	42
Decreased Hemodynamic Responses in Left Parietal Lobule and Left Inferior Parietal Lobule in Older Adults with Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study	41
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas	41
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	41
Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study	41
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity	39
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease	39
Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder	38
Disruptions of deep medullary veins and MRI indices of glymphatic function in cerebral small vessel disease	38
Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors	38
Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer’s Disease	37
Characterization of Early Alzheimer’s Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study	36
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease	36
Associations of the Harvard Automated Phone Task and Alzheimer’s Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings	35
Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition	35
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	35
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding	35
JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1	35
Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective	34
Needs of people living with young-onset dementia and family carers, explored by dementia subtype, phase in the disease process, and living setting: A scoping review	34
Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer’s Disease	34
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer’s Disease Spectrum	34
Difficulties with Activities of Daily Living and Receipt of Care Among Older Adults with Cognitive Impairment: Differences Between Those Living Alone and Those Living with Others	33
The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis	33
α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer’s Disease	33
Fall Risk, Sleep Behavior, and Sleep-Related Movement Disorders in Young Urbanites Exposed to Air Pollution	32
Methylcobalamin Alleviates Neuronal Apoptosis and Cognitive Decline Induced by PM2.5 Exposure in Mice	32
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	32
Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial	32
Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis	32
Association of Anemia with Cognitive Function and Dementia Among Older Adults: The Role of Inflammation	32
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia	32
Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease	32
Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic	32
Association of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: New Entity or Coincidence? A Case Series	31
The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study	31
Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia	31
Sleep disturbances and language function impairment in the elderly: Evidence of limbic and prefrontal tracts involvement	31
Fatty Acid-Binding Protein 3 Is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults	31
Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons	31
Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer’s Disease	30
Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice	30

Incident Dementia After Spontaneous Intracerebral Hemorrhage	30
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease	29
Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer’s Disease Rat Model	29
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	29
Subjective Cognitive Decline Is Associated with Health-Related Quality of Life in the Middle-Aged to Elderly Population	28
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia	28
Hydrate to keep the amyloid away	28
Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development	28
Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer’s Type Neurodegeneration	28
Corrigendum to “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome”	28
Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer’s Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks	27
Case Identification and Characterization of Migrants with Dementia in the Lazio Region Using Health Administrative Data	27
Attentional Control in Subjective Cognitive Decline	27
Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk	27
Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer’s Disease	27
Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer’s Disease	27
IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease	27
Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial	27
Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011–2014)	26
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	26
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging	26
Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial	26
Lucidity in deeply forgetful people: A national U.S. survey of caregivers’ reactions	26
Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES	26
Peripheral blood immune cell phenotypes and Alzheimer’s disease: A mediation Mendelian randomization study	26
Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial	26
Associations Between TREML2 Gene Variants and Alzheimer’s Disease: Biomarkers, Neuroimage, and Cognition	25
Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies	25
Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study	25
Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes	25
Societal Costs of Dementia: 204 Countries, 2000–2019	25
Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences	25
Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding	25
Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects	25
go4cognition: Combined Physiological and Cognitive Intervention in Mild Cognitive Impairment	25
Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up	25
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease	25
Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer’s Disease	25
Is Carer Management Style Associated with Longitudinal Functional Decline in Dementia?	24
Predictors of MRI-estimated brain iron deposition in dementia and Parkinson's disease-associated subcortical regions: Genetic and observational analysis in UK Biobank	24
Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment	24
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease	24
Effects of Type 2 Diabetes on the Neuropsychological Profile in Mild Cognitive Impairment	24
Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023	24
Multifactorial Causation of Alzheimer’s Disease Due to COVID-19	24
Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services	24
Factors Associated with Apathy in Alzheimer’s Disease: A Cross-Sectional Analysis of the Texas Alzheimer’s Research and Care Consortium (TARCC) Study	24
A nomogram including serum iron metabolism-related indicator and cerebral microbleeds for predicting vascular cognitive impairment in patients	24
Getting Insight to the Lived Emotional Experience of People with Alzheimer’s Disease Shortly After Diagnosis: A Phenomenological Approach	24
Prevalence and Factors Associated with Subjective Memory Complaint in a Semi-Rural Community in Chile	24
Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers	24
Mild Cognitive Impairment, Reversion Rates, and Associated Factors: Comparison of Two Diagnostic Approaches	24
Association of Kidney Function with Risk of Incident Dementia: A Prospective Cohort Study of 275,167 UK Biobank Participants	24
Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award	24
The Diagnostic Value of a Short Memory Test: The TNI-93	24
Exploring the Genetic Heterogeneity of Alzheimer’s Disease: Evidence for Genetic Subtypes	23
A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials	23
Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer’s Disease	23
Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer’s Disease and Cognitive Function	23
Non-Modifiable Factors as Moderators of the Relationship Between Physical Activity and Brain Volume: A Cross-Sectional UK Biobank Study	23
Associations of Leisure Activities and Sleep Duration with Cognitive Function: A Nationwide Prospective Cohort Study of Chinese Old Adults	23
Phosphorylation and Glycosylation of Amyloid-β Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer’s Disease	23
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer’s Disease and Cognitively Normal Individuals	23
Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study	23
Hyperglycemia Aggravates the Cerebral Ischemia Injury via Protein O-GlcNAcylation	23
Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife	22
Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer’s Disease Stage	22
Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease transition	22
Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review	22
The role of carotenoids from red mamey fruit (Pouteria sapota) against amyloid-β monomers in Alzheimer's disease: Computational analysis and ADMET prediction	22
Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people	22
Code-Based Algorithms for Identifying Dementia in Electronic Health Records: Bridging the Gap Between Theory and Practice	22
Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease	22
Sex Modifies the Associations of APOE ɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer’s Disease	22
Multivariate Assessment of Lipoxidative Metabolites, Trace Biometals, and Antioxidant and Detoxifying Activities in the Cerebrospinal Fluid Define a Fingerprint of Preclinical Stages of Alzheimer’s Di	22
Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies	22
Hearing loss, plasma neurodegenerative biomarkers, and cognitive function: Independent and additive effects	22
Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer’s Disease	22
The Impact of Misaligned Perceived and Objective Fall Risk in Cognitively Impaired Older People	22
Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease	21

Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer’s Disease and Longitudinal Change in Hippocampus Function	21
Physical Activity Self-Report Is Not Reliable Among Subjects with Mild Vascular Cognitive Impairment: The AFIVASC Study	21
What Impact Does the Diagnosis of Mild Cognitive Impairment Have on the Wellbeing, Everyday Behavior, and Healthcare Utilization of People and Their Carers? A Systematic Review	21
Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice	21
No Influence of Age-Related Hearing Loss on Brain Amyloid-β	21
The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review	21
Effects of Intermittent Hypoxia Protocols on Cognitive Performance and Brain Health in Older Adults Across Cognitive States: A Systematic Literature Review	21
Acute cerebral blood flow response to heavy cream ingestion in older adults: A non-randomized pilot study	21
Alzheimer’s Disease Is a Multi-Organ Disorder: It May Already Be Preventable	21
Developing an Image-Based Deep Learning Framework for Automatic Scoring of the Pentagon Drawing Test	21
Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition	21
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease	21
Evaluation of early-phase ¹⁸ F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with ¹⁸ F-FDG PE	21
Validation of the Updated “LIfestyle for BRAin health” (LIBRA) Index in the English Longitudinal Study of Ageing and Maastricht Aging Study	20
Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans	20
Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer’s Disease and Non-Demented Individuals	20
A Pilot Study of Near-Infrared Light Treatment for Alzheimer’s Disease	20
Factors influencing rates of unsupervised assessment of short-term learning in cognitively unimpaired adults	20
Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center	20
COVID-19 and Alzheimer’s Disease: What Is the Connection?	20
Meaning in life and neurobiomarkers of brain health in the UK Biobank	20
A Decade of Decline in Serious Cognitive Problems Among Older Americans: A Population-Based Study of 5.4 Million Respondents	20
Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer’s Disease	20
Efficacy of a Virtual Education Program for Family Caregivers of Persons Living with Dementia	20
Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population	20
Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer’s Disease	20
Neutrophil percentage-to-albumin ratio is associated with cognitive function in adults aged over 60 years: An analysis of data from the NHANES 2011–2014	20
Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements	20
Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer’s disease	20
Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentratio	20
Aqueous and Plasma Levels of Phosphorylated Tau 181 in Individuals with Normal Cognition	20
The relationship between postoperative cognitive dysfunction and cerebral small vessel disease: A comprehensive review	20
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer’s Disease and Related Disorders	20
TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer’s Disease	19
Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes	19
Identification of Major Cognitive Disorders in Self-Reported versus Administrative Health Data: A Cohort Study in Quebec	19
Longitudinal Body Weight Change, Visit-To-Visit Body Weight Fluctuation, and Cognitive Decline Among Older Adults	19
Protocol for a Mixed-Methods Process Evaluation of BetterBrains: A Person-Centered Online Intervention to Delay Cognitive Decline in Adults at Risk of Dementia	19
A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study)	19
Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease	19
Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer’s Disease	19
Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment	19
Do They Align? Congruence Between Patient Preferences of People Living with Cognitive Impairments and Physicians’ Judgements for Person-Centered Care: An Analytic Hierarchy Process Study	19
Sloping Shoulders Sign: A Practical Radiological Sign for the Differentiation of Alzheimer’s Disease and Argyrophilic Grain Disease	19
The role of built and social environments in Alzheimer's disease dementia prevalence in the United States: A machine learning approach	19
An Alzheimer’s Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease	18
Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease	18
miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease	18
Exploring the Association Between Opioid Use Disorder and Alzheimer’s Disease and Dementia Among a National Sample of the U.S. Population	18
Effects of Apolipoprotein E ɛ4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia	18
Physical Activity and Cognition in Sedentary Older Adults: A Systematic Review and Meta-Analysis	18
The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease	18
Assessment of diffusivity along the perivascular space in early- and late-onset Alzheimer's disease	18
Biomarkers and Risk Assessment of Alzheimer’s Disease in Low- and Middle-Income Countries	18
Biomarkers and Mindfulness: A Way Forward	18
Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer’s Disease Pathology	18
Identifying Comorbidity Patterns in People with and without Alzheimer’s Disease Using Latent Dirichlet Allocation	18
Association Between High Serum Tetrahydrofolate and Low Cognitive Functions in the United States: A Cross-Sectional Study	18
Sex differences in cognitive trajectories and practice effects in a cohort of older Londoners: The role of risk factors	18
Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort	18
Dementia Knowledge, Attitude toward Dementia, and Confidence in Dementia Care: Impact of a Dementia Training on German Nursing Students	18
Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process	18
Structural white matter connectivity differences independent of gray matter loss in mild cognitive impairment with neuropsychiatric symptoms: Early indicators of Alzheimer's disease using network-base	18
Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia	18
Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer’s Disease	18
Towards characterizing subjective cognitive decline in older adults	18
Physician Diagnosis and Knowledge of Mild Cognitive Impairment	18
Causal Association Between mTOR-Dependent Protein Levels and Alzheimer’s Disease: A Mendelian Randomization Study	18
Concerning the debate about homocysteine, B vitamins, and dementia	18
Digital Biomarkers for the Assessment of Non-Cognitive Symptoms in Patients with Dementia with Lewy Bodies: A Systematic Review	17
The Association Between Standard Electrocardiography and Cerebral Small Vessel Disease in a Memory Clinic Study	17
Patterns of Limitation in Physical Function in Late Midlife Associated with Late-Onset Alzheimer’s Disease and Related Dementias: A Cluster Analysis	17
Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells	17
Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy	17
Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer’s Disease	17
Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study	17
Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers	17
Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid	17
Amyloid-Negative, Neurodegeneration-Negative Amnestic Mild Cognitive Impairment	17
Organized Registration for the Assessment of Dementia by the Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry: Current Status and Perspectives of Mild Cognitive Impairment	17
Sex Differences in Dementia, Cognition, and Health in the Cognitive Function and Ageing Studies (CFAS)	17
Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?	17
A Longitudinal Study of Functional Unmet Need Among People with Dementia	17
Characterization of Apathy-Like Behaviors in Mouse Models of Down Syndrome	17
A Mini-Mental State Examination Formula May Help to Distinguish Alzheimer’s Disease from Dementia with Lewy Bodies	17
How much can biomarkers explain sociodemographic inequalities in cognitive dysfunction and cognitive impairment? Results from a machine learning model in the Health and Retirement Study	17
Toward Pre-Diagnostic Detection of Dementia in Primary Care	17
Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1	17
Projecting the Likely Impact of COVID-19 Infections on the Prevalence of Dementia in the United States	17
Gamma Frequency Inhibits the Secretion and Aggregation of Amyloid-β and Decreases the Phosphorylation of mTOR and Tau Proteins in vitro	17
Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer’s Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle	17
The role of vitamins in dementia prevention and cognitive health: A comprehensive review	17
Diffusion Imaging of Gray Matter Microstructure in Alzheimer’s Disease	17
Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain	17
Association of Age with Dual-Task Objective Cognitive Indicators and Gait Parameters in Older Adults	17